Literature DB >> 18699744

The antiviral activities of artemisinin and artesunate.

Thomas Efferth1, Marta R Romero, Dana G Wolf, Thomas Stamminger, Jose J G Marin, Manfred Marschall.   

Abstract

Traditional Chinese medicine commands a unique position among all traditional medicines because of its 5000 years of history. Our own interest in natural products from traditional Chinese medicine was triggered in the 1990s, by artemisinin-type sesquiterpene lactones from Artemisia annua L. As demonstrated in recent years, this class of compounds has activity against malaria, cancer cells, and schistosomiasis. Interestingly, the bioactivity of artemisinin and its semisynthetic derivative artesunate is even broader and includes the inhibition of certain viruses, such as human cytomegalovirus and other members of the Herpesviridae family (e.g., herpes simplex virus type 1 and Epstein-Barr virus), hepatitis B virus, hepatitis C virus, and bovine viral diarrhea virus. Analysis of the complete profile of the pharmacological activities and molecular modes of action of artemisinin and artesunate and their performance in clinical trials will further elucidate the full antimicrobial potential of these versatile pharmacological tools from nature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18699744     DOI: 10.1086/591195

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  131 in total

1.  Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.

Authors:  Biswa Nath Sharma; Manfred Marschall; Christine Hanssen Rinaldo
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 2.  How we treat cytomegalovirus in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh; Per Ljungman
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

3.  Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin.

Authors:  Gundula Min-Oo; Anny Fortin; Jean-François Poulin; Philippe Gros
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

Review 4.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

5.  A Pragmatic Approach to Immunity & Respiratory Viral Infections.

Authors:  Todd A Born
Journal:  Integr Med (Encinitas)       Date:  2020-10

6.  Artesunate protects pancreatic beta cells against cytokine-induced damage via SIRT1 inhibiting NF-κB activation.

Authors:  L Yu; J F Chen; X Shuai; Y Xu; Y Ding; J Zhang; W Yang; X Liang; D Su; C Yan
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

Review 7.  New developments in the management of cytomegalovirus infection after solid organ transplantation.

Authors:  Albert J Eid; Raymund R Razonable
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

8.  Human embryonic lung fibroblasts treated with artesunate exhibit reduced rates of proliferation and human cytomegalovirus infection in vitro.

Authors:  Ai-Hong Zeng; Yang-Ying Ou; Ming-Ming Guo; Xuan Dai; De-Zhi Zhou; Rui Chen
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

9.  Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers.

Authors:  Ravit Arav-Boger; Ran He; Chuang-Jiun Chiou; Jianyong Liu; Lauren Woodard; Andrew Rosenthal; Lorraine Jones-Brando; Michael Forman; Gary Posner
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

10.  Synthesis of spiroannulated and 3-arylated 1,2,4-trioxanes from mesitylol and methyl 4-hydroxytiglate by photooxygenation and peroxyacetalization.

Authors:  Axel G Griesbeck; Lars-Oliver Höinck; Jörg M Neudörfl
Journal:  Beilstein J Org Chem       Date:  2010-06-07       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.